PharmEnable Therapeutics vs PostEra
PharmEnable Therapeutics
Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innovative small molecule drugs
14 employees · est. 2016 · Cambridge, United Kingdom
PostEra
Medicinal Chemistry powered by Machine Learning
41 employees · est. 2019 · Boston, United States
PharmEnable Therapeutics is the older company (2016 vs 2019).
Side-by-Side Comparison
| Metric | PharmEnable Therapeutics | PostEra |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2019 |
| Headquarters | ||
| Headquarters | Cambridge, United Kingdom | Boston, United States |
| Employees | ||
| Employees | 14 | 41 |
| Industry | ||
| Industry | Biotechnology, Life Sciences, Pharmaceutical | AI, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Seed | Series A |
| Total Funding | ||
| Total Funding | $9.30M | $24.13M |
| Funding Rounds | ||
| Funding Rounds | 4 | 4 |
| Services | ||
| Services | AI-driven drug discovery, Development of small molecule drugs, Therapeutic target identification, Pipeline development | AI Platform for Drug Discovery, Medicinal Chemistry, Pharmaceutical Collaborations, Drug Development |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotechnology firms, Medical researchers, Healthcare providers | Pharmaceutical Companies, Biotechnology Firms, Medical Research Institutions |
| Taxonomy | ||
| Taxonomy | AI-enabled Drug DiscoverySmall Molecule DrugsChemical Novelty3D Chemical Space ExplorationOncology TherapeuticsNeurology Therapeutics +6 | AI-first BiotechMedicinal ChemistryMachine Learning In Drug DiscoveryWomen’s HealthFertility TreatmentClinical Candidates +9 |
| Website | ||
| Website | pharmenabletx.com | postera.ai |
About PharmEnable Therapeutics
PharmEnable Therapeutics, founded in 2016, is a pioneering biopharmaceutical company operating at the cutting edge of Biotechnology, Life Sciences, and Pharmaceutical industries. Based in the United Kingdom and a spin-off from the University of Cambridge, the company is renowned for its slogan: "Har...
About PostEra
PostEra, founded in 2019, is a pioneering startup at the intersection of AI and biotechnology, headquartered in the United States. The company leverages its proprietary AI platform, Proton, to revolutionize medicinal chemistry, aiming to accelerate the discovery and development of new medicines. Em...
Also comparing in this category
Comparing more than these two?
Get PharmEnable Therapeutics, PostEra and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does PharmEnable Therapeutics compare?
A PDF of PharmEnable Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare PharmEnable Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at PharmEnable Therapeutics on 11 Mar 2026, and PostEra on 14 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.